| Literature DB >> 27490109 |
Gwendoline Deslyper1, Thomas J Colgan2, Andrew J R Cooper3, Celia V Holland3, James C Carolan1.
Abstract
The helminth Ascaris causes ascariasis in both humans and pigs. Humans, especially children, experience significant morbidity including respiratory complications, growth deficits and intestinal obstruction. Given that 800 million people worldwide are infected by Ascaris, this represents a significant global public health concern. The severity of the symptoms and associated morbidity are related to the parasite burden and not all hosts are infected equally. While the pathology of the disease has been extensively examined, our understanding of the molecular mechanisms underlying resistance and susceptibility to this nematode infection is poor. In order to investigate host differences associated with heavy and light parasite burden, an experimental murine model was developed utilising Ascaris-susceptible and -resistant mice strains, C57BL/6J and CBA/Ca, respectively, which experience differential burdens of migratory Ascaris larvae in the host lungs. Previous studies identified the liver as the site where this difference in susceptibility occurs. Using a label free quantitative proteomic approach, we analysed the hepatic proteomes of day four post infection C57BL/6J and CBA/Ca mice with and without Ascaris infection to identify proteins changes potentially linked to both resistance and susceptibility amongst the two strains, respectively. Over 3000 proteins were identified in total and clear intrinsic differences were elucidated between the two strains. These included a higher abundance of mitochondrial proteins, particularly those associated with the oxidative phosphorylation pathway and reactive oxygen species (ROS) production in the relatively resistant CBA/Ca mice. We hypothesise that the increased ROS levels associated with higher levels of mitochondrial activity results in a highly oxidative cellular environment that has a dramatic effect on the nematode's ability to successfully sustain a parasitic association with its resistant host. Under infection, both strains had increased abundances in proteins associated with the oxidative phosphorylation pathway, as well as the tricarboxylic acid cycle, with respect to their controls, indicating a general stress response to Ascaris infection. Despite the early stage of infection, some immune-associated proteins were identified to be differentially abundant, providing a novel insight into the host response to Ascaris. In general, the susceptible C57BL/6J mice displayed higher abundances in immune-associated proteins, most likely signifying a more active nematode cohort with respect to their CBA/Ca counterparts. The complement component C8a and S100 proteins, S100a8 and S100a9, were highly differentially abundant in both infected strains, signifying a potential innate immune response and the importance of the complement pathway in defence against macroparasite infection. In addition, the signatures of an early adaptive immune response were observed through the presence of proteins, such as plastin-2 and dipeptidyl peptidase 1. A marked decrease in proteins associated with translation was also observed in both C57BL/6J and CBA/Ca mice under infection, indicative of either a general response to Ascaris or a modulatory effect by the nematode itself. Our research provides novel insights into the in vivo host-Ascaris relationship on the molecular level and provides new research perspectives in the development of Ascaris control and treatment strategies.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27490109 PMCID: PMC4974003 DOI: 10.1371/journal.pntd.0004837
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Label free quantitative proteomic analysis of liver left lobes of C57BL/6J and CBA/Ca mice with and without Ascaris infection.
(A) Principal component analysis (PCA) of the left lobe liver proteomes of C57BL/6J and CBA/Ca mice with and without Ascaris infection. A clear distinction can be observed between the strains and the distinction between C57BL/6J infected and controls is greater than that for CBA/Ca infected and controls. (B) Two-way unsupervised hierarchical clustering of the median protein expression values of all statistically significant differentially abundant proteins. Hierarchical clustering (columns) resolved four distinct clusters comprising the three replicates from their original sample groups and five protein cluster (rows) based on expression profile similarities. (C) The table shows a selection of significantly enriched GOBP and GOCC terms (Fisher’s exact test, FDR < 2%) in each of the identified protein clusters.
Numbers of statistically significant differentially abundant (SSDA) proteins (t-tests; p<0.05) identified among CBA/Ca and C57BL/6J infected and uninfected samples.
The number of proteins before and after imputation, the range of Log2 fold differences and the number of proteins associated with well represented KEGG or gene ontology processed or pathways are given. Numbers in parenthesis represent the total number of proteins identified within each process. OXPHOS: oxidative phosphorylation, FC: fold change.
| Protein Processes | |||||||
|---|---|---|---|---|---|---|---|
| T-test Comparison | Number of proteins | Range of FC Difference | Mitochondria (324) | OXPHOS (80) | Immune system (106) | Ribosomes (73) | Iron ion binding (71) |
| C57BL/6J infected: C57BL/6J control | 456/479 | -8.2/7.2 | 81 | 22 | 20 | 48 | 21 |
| CBA/Ca infected: CBA/Ca control | 169/193 | -6.1/5.9 | 17 | 5 | 14 | 35 | 5 |
| CBA/Ca control: C57BL/6J control | 320/354 | -6.7/13.6 | 72 | 25 | 14 | 9 | 11 |
| CBA/Ca infected: C57BL/6J infected | 374/410 | -8.1/9.2 | 78 | 30 | 15 | 16 | 14 |
* pre-imputation/post imputation
Fig 2Volcano plots of all identified proteins based on relative abundance differences between C57BL/6J and CBA/Ca mice with and without Ascaris.
Volcano plots showing the distribution of quantified proteins according to p value (−log10 p-value) and fold change (log2 mean LFQ intensity difference). Proteins above the line are considered statistically significant (p-value <0.05) and those to the right and left of the vertical lines indicate relative fold changes ≥ 1.5. The top 20 differentially abundant proteins are annotated and all proteins associated with the mitochondria (blue), immune system (green) and translation (orange) are highlighted for (A) C57BL/6J infected and control, (B) CBA/Ca infected and control mice, (C) CBA/Ca control and C57BL/6J control and (D) CBA/Ca infected and C57BL/6J infected mice.
Fig 3Interaction network analysis of up regulated proteins in C57BL/6J and CBA/Ca mice with and without Ascaris infection.
Protein interaction information was obtained from the STRING database using gene lists extracted for statistically significant differentially abundant (SSDA) proteins from pair wise t-tests (p< 0.05). Each node represents a protein and each connecting line represents an interaction, the extent of evidence for which is represented by the width of the line. Statistically enriched KEGG and biological process Gene Ontology (GO) descriptors were examined to identify clusters of proteins enriched within SSDA protein of increased abundance for (A) C57BL/6J infected in comparison to C57BL/6J controls, (B) C57BL/6J controls in comparison to C57BL/6J infected, (C) CBA/Ca infected in comparison to CBA/Ca controls and (D) CBA/Ca controls in comparison to CBA/Ca infected mice.
Statistically significant differentially abundant (SSDA) proteins associated with immune processes.
Log2 fold differences from two pairwise t-tests (p < 0.05) are given for (i) CBA: CBA/Ca infected and CBA/CaC57 control and (ii) C57: C57BL/6J infected and C57BL/6J control. The number of immune associated proteins and relative fold change differences are for the majority greater in C57BL/6J than CBA/Ca Ascaris-infected mice. Immune functions were retrieved by searching the UniProt ID on the UniProt Knowledgebase (http://www.uniprot.org/).
| Gene names | Protein names | Uniprot ID | T-test Comparison | Log2 fold Difference | Immune Function |
|---|---|---|---|---|---|
| S100a8 | Protein S100-A8 | P27005 | C57; CBA | 7.2; 5.9 | Innate immune response; Leukocyte migration in inflammatory response; Neutrophil chemotaxis; Positive regulation of inflammatory response; Autophagy; Positive regulation of apoptotic signalling |
| S100a9 | Protein S100-A9 | P31725 | C57; CBA | 6.1; 4.7 | Actin cytoskeleton reorganisation; Leukocyte chemotaxis; Positive regulation of inflammatory response; Positive regulation of blood coagulation; Autophagy |
| Ctsc | Dipeptidyl peptidase 1 | P97821 | CBA; C57 | 5.5; 1.3 | T cell mediated cytotoxicity; Positive regulation of apoptotic signalling pathway |
| Lgals3 | Galectin-3 | P16110 | CBA; C57 | 5.5; 1.7 | IgE binding; Eosinophil/macrophage/monocyte/neutrophil Chemotaxis; Innate immune response |
| Anxa1 | Annexin A1 | P10107 | C57 | 4.4 | Granulocyte/monocyte chemotaxis; Phagocytosis; Negative regulation of T-helper 2 cell differentiation; Neutrophil homeostasis; Positive regulation of T-helper 1 cell differentiation; Positive regulation of interleukin-1 and 2 production; Positive regulation of neutrophil apoptotic process; Hepatocyte differentiation |
| Coro1a | Coronin-1A | O89053 | CBA; C57 | 3.7; 3.0 | Leukocyte chemotaxis; Natural killer cell degranulation Phagocytosis; Cellular response to interleukin-4; Positive regulation of T cell activation and proliferation |
| Lcn2 | Neutrophil gelatinase-associated lipocalin | P11672 | C57 | 3.4 | Cellular response to hydrogen peroxide; Cellular response to interleukin-1; Innate immune response |
| Vtn | Vitronectin | P29788 | C57 CBA | 2.0 1.7 | Immune response; Positive regulation of smooth muscle cell migration; Positive regulation of receptor-mediated |
| Ilf3 | Interleukin enhancer-binding factor 3 | Q9Z1X4 | CBA | 2.0 | Defense response to virus |
| Fth1 | Ferritin heavy chain | P09528 | C57 | 1.1 | Immune response; Negative regulation of cell proliferation; Negative regulation of necrotic cell death |
| Ahsg | Alpha-2-HS-glycoprotein | P29699 | C57 | 0.9 | Acute-phase response; Positive regulation of phagocytosis; Regulation of inflammatory response |
| Irak4 | Interleukin-1 receptor-associated kinase 4 | Q8R4K2 | C57 | 0.9 | Neutrophil mediated immunity; JNK cascade; Positive regulation of I-kappaB kinase/NF-kappaB signalling |
| Lgals1 | Galectin-1 | P16045 | C57 | 0.8 | Positive regulation of I-kappaB kinase/NF-kappaB signalling; T cell costimulation |
| Msn | Moesin | P26041 | C57; CBA | 0.8; 0.6 | Leukocyte cell-cell adhesion; Leukocyte migration |
| Anxa2 | Annexin A2 | P07356 | C57 | 0.8 | Angiogenesis; Fibrinolysis; Positive regulation of fibroblast proliferation |
| Plg | Plasminogen | P20918 | C57 CBA | 0.8 0.6 | Mononuclear cell migration; Negative regulation of angiogenesis; Tissue regeneration |
| Pafah1b1 | Platelet-activating factor acetylhydrolase IB subunit alpha | P63005 | C57 | 0.7 | Actin cytoskeleton organization; Negative regulation of JNK cascade; Positive regulation of cytokine-mediated signaling; Regulation of microtubule motor activity |
| Serpinf2 | Alpha-2-antiplasmin | Q61247 | C57 | 0.6 | Acute-phase response; Positive regulation of stress fibre assembly; Regulation of blood vessel size by renin-angiotensin; Negative regulation of plasminogen activation |
| Hpx | Hemopexin | Q91X72 | C57 | 0.6 | Heme metabolic process; Positive regulation of immunoglobulin production; Positive regulation of interferon-gamma-mediated signalling; Positive regulation of response to interferon |
| C8a | Complement component C8 alpha chain | Q8K182 | C57; CBA | 0.6; 0.6 | Complement activation; Cytolysis |